Pathology and Genetics: Tumours of Haematopoietic and Lymphoid Tissues (World Health Organization Classification of Tumours) by Elaine Sarkin Jaffe

Pathology and Genetics: Tumours of Haematopoietic and Lymphoid Tissues (World Health Organization Classification of Tumours)



Download eBook




Pathology and Genetics: Tumours of Haematopoietic and Lymphoid Tissues (World Health Organization Classification of Tumours) Elaine Sarkin Jaffe ebook
Publisher:
Page: 352
ISBN: 9283224116, 9789283224112
Format: pdf


In World Health Organization Classification of Tumours. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. Harris NL JE, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, Lister TA, Bloomfield CD: The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. The criteria currently used to distinguish between Burkitt lymphoma (BL) and DLBCL, is based on differences in morphology, immunophenotype, and genetic abnormalities. There followed a series of reports, predominantly from Japan and East Asia, demonstrating the striking pathological feature of EBV-infected T or NK cells in the blood or tissue of affected patients [20-26]. The patient was treated with chemotherapy (CHOP: cyclophosphamide, lymphoid tissue (MALT) type. Pathology and Genetics of tumors of haematopoietic and lymphoid system. EKLF has surprisingly been associated with tumors such as cancer in the endometrial epithelial cells, and is increased by treatment with tamoxifen or oestrogen [27]. Extra-nodal NK/T -cell lymphoma (ENKTL) is a relatively recently characterised clinicopathological entity, being formally incorporated into the WHO classification of haematopoietic and lymphoid tumours in 1999 [86]. EKLF mRNA expression is correlated with expression .. Pathology and genetics of tumours of the In World Health Organization Classification of tumour. Within the GC B cell reaction or maintenance of mature B cells additional factors are involved including IL21, CD40L (TNFSF5 / CD154) or tumour necrosis factor superfamily member 13b (BAFF / TNFSF13b / CD257) [2,4-6,8]. The pathological diagnosis was CD5-positive marginal zone B-cell lymphoma of the mucosa-associated lymphoid tissue (MALT) of the lung.